- Home
- WFF vs NRSN Comparison
WFF vs NRSN Comparison
Compare WFF & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFF
- NRSN
- Stock Information
- Founded
- WFF 1984
- NRSN 2017
- Country
- WFF Malaysia
- NRSN Israel
- Employees
- WFF N/A
- NRSN N/A
- Industry
- WFF Miscellaneous manufacturing industries
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- WFF Consumer Discretionary
- NRSN Health Care
- Exchange
- WFF Nasdaq
- NRSN Nasdaq
- Market Cap
- WFF 22.4M
- NRSN 26.0M
- IPO Year
- WFF 2025
- NRSN 2021
- Fundamental
- Price
- WFF $0.90
- NRSN $1.18
- Analyst Decision
- WFF
- NRSN Buy
- Analyst Count
- WFF 0
- NRSN 2
- Target Price
- WFF N/A
- NRSN $14.00
- AVG Volume (30 Days)
- WFF 112.3K
- NRSN 329.6K
- Earning Date
- WFF 01-01-0001
- NRSN 09-29-2025
- Dividend Yield
- WFF N/A
- NRSN N/A
- EPS Growth
- WFF N/A
- NRSN N/A
- EPS
- WFF 0.00
- NRSN N/A
- Revenue
- WFF $4,572,290.00
- NRSN N/A
- Revenue This Year
- WFF N/A
- NRSN N/A
- Revenue Next Year
- WFF N/A
- NRSN N/A
- P/E Ratio
- WFF $185.11
- NRSN N/A
- Revenue Growth
- WFF N/A
- NRSN N/A
- 52 Week Low
- WFF $0.81
- NRSN $0.80
- 52 Week High
- WFF $29.26
- NRSN $2.60
- Technical
- Relative Strength Index (RSI)
- WFF N/A
- NRSN 43.76
- Support Level
- WFF N/A
- NRSN $1.02
- Resistance Level
- WFF N/A
- NRSN $1.17
- Average True Range (ATR)
- WFF 0.00
- NRSN 0.10
- MACD
- WFF 0.00
- NRSN 0.03
- Stochastic Oscillator
- WFF 0.00
- NRSN 60.53
About WFF WF Holding Limited Ordinary Shares
WF Holding Ltd is a manufacturer of FRP products based in Malaysia. It has been providing high-quality and durable FRP products to various industries, including, among others, chemical processing, water and wastewater treatment, and power generation. Its products range from tanks, pipes, ducts, gratings and other custom-made FRP products. The company uses advanced production technology and equipment and has obtained various certifications. Its manufacturing capabilities allow the company to design and fabricate products that meet the specific needs of its clients, ensuring high-quality and reliable performance.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.